Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis

American Journal of Gastroenterology

Volumn 106, Issue 4, 2011, Pages 771-777

  Leblanc, S ^a   Allez, M ^a   Seksik, P ^b   Flourie B ^c   Peeters, H ^d   Dupas, J L ^e   Bouguen, G ^f   Peyrin Biroulet, L ^g   Duclos, B ^h   Bourreille, A ⁱ   Dewit, O ^j   Bouhnik, Y ^k   Michetti, P ^l   Chaussade, S ^m   Saussure, P ⁿ   Mary, J Y ^o   Colombel, J F ^p   Lemann M ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

^e AMIENS UNIVERSITY HOSPITAL   (France)

^f RENNES UNIVERSITY HOSPITAL   (France)

^g CHU NANCY BRABOIS   (France)

^h UNIVERSITY HOSPITAL OF STRASBOURG   (France)

ⁱ HÔTEL DIEU   (France)

^j UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^k BEAUJON HOSPITAL   (France)

^l LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^m Université Paris Diderot ^*  (France)

ⁿ HUG   (Switzerland)

^o INSERM   (France)

^p LILLE UNIVERSITY HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; INFLIXIMAB;

ADOLESCENT; ADULT; ARTICLE; COLITIS; COLON RESECTION; DEATH; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; INDETERMINATE COLITIS; INFECTION; KIDNEY DISEASE; LIVER DISEASE; LUNG EMBOLISM; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; SIDE EFFECT; SMALL INTESTINE OBSTRUCTION; ULCERATIVE COLITIS;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CHILD; COLECTOMY; COLITIS, ULCERATIVE; CYCLOSPORINE; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFECTION; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; SALVAGE THERAPY; STEROIDS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79953788483     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.62     Document Type: Article

References (31)

1. Truelove SC, Jewell DP. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet 1974; 1: 1067-70.
2. Truelove SC, Willoughby CP, Lee EG et al Further experience in the treat-ment of severe attacks of ulcerative colitis. Lancet 1978;2:1086-8. (Pubitemid 9052873)
3. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; f nal report on a therapeutic trial. BMJ 1955; 2: 1041-8.
4. Lichtiger S, Present DH, Kornbluth A et al Cyclosporine in severe ulcera-tive colitis refractory to steroid therapy N Engl J Med 1994;330:1841-5. (Pubitemid 24188135)
5. Carbonnel F, Boruchowicz A, Duclos B et al. Intravenous cyclosporine in attacks of ulcerative colitis: short-term and long-term responses. Dig Dis Sci 1996;41:2471-6.
6. Cohen RD, Brodsky AL, Hanauer SB. A comparison of the quality of life in patients with severe ulcerative colitis af er total colectomy versus medical treatment with intravenous cyclosporin. Infamm Bowel Dis 1999;5:1-10.
7. DHaens G, Lemmens L, Geboes K et al. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology 2001;120:1323-9. (Pubitemid 32322305)
8. Hyde GM, T illainayagam AV, Jewell DP Intravenous cyclosporin as rescue therapy in severe ulcerative colitis: time for a reappraisal? Eur J Gastroenterol Hepatol 1998;10:411-3. (Pubitemid 28241428)
9. Stack WA, Long RG, Hawkey CJ. Short-and long-term outcome of patients treated with cyclosporin for severe acute ulcerative colitis. Aliment Phar-macol Ter 1998;12:973-8. (Pubitemid 28454379)
10. Van Gossum A, Schmit A, Adler M et al Short-and long-term Effcacy of cyclosporin administration in patients with acute severe ulcerative colitis. Belgian IBD Group. Acta Gastroenterol Belg 1997; 60: 197-200. (Pubitemid 27489427)
11. Van Assche G, D'Haens G, Noman M et al. Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology 2003;125:1025-31. (Pubitemid 37193449)
12. Jarnerot G, Hertervig E, Friis-Liby I et al. Infiximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-con-trolled study Gastroenterology 2005;128:1805-11. (Pubitemid 40824691)
13. Gustavsson A, Jarnerot G, Hertervig E et al Clinical trial: colectomy af er rescue therapy in ulcerative colitis-3-year follow-up of the Swedish-Danish controlled infiximab study Aliment Pharmacol Ter 2010;32:984-9.
14. Maser EA, Deconda D, Lichtiger S et al. Cyclosporine and Infiximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis. Clin Gastroenterol Hepatol 2008; 6: 1112-6.
15. Lam EC, Bailey RJ. Infiximab salvage therapy af er cyclosporine in an acute fare of chronic ulcerative colitis. Can J Gastroenterol 2003;17:198-200. (Pubitemid 36608959)
16. Manosa M, Lopez San Roman A, Garcia-Planella E et al. Infiximab rescue therapy af er cyclosporin failure in steroid-refractory ulcerative colitis. Digestion 2009;80:30-5.
17. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology Practice Parameters Committee. Am J Gastroenterol 2010;105:501-23;quiz 524.
18. Travis SP, Stange EF, Lémann M et al. European evidence-based Consensus on the management of ulcerative colitis: current management. J Crohns Colitis 2008; 2: 24-62. (Pubitemid 351179488)
19. Carbonnel F, Lavergne A, Lemann M et al. Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity Dig Dis Sci 1994;39:1550-7. (Pubitemid 24246449)
20. Campbell S, Travis S, Jewell D. Ciclosporin use in acute ulcerative colitis: a long-term experience. Eur J Gastroenterol Hepatol 2005;17:79-84. (Pubitemid 40128931)
21. Cohen RD, Stein R, Hanauer SB. Intravenous cyclosporin in ulcerative colitis: a fve-year experience. Am J Gastroenterol 1999;94:1587-92. (Pubitemid 29260450)
22. Gustavsson A, Halfvarson J, Magnuson A et al Long-term colectomy rate af-ter intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatmenTera. Am J Gastroenterol 2007; 102: 2513-9. (Pubitemid 47631769)
23. Moskovitz DN, Van Assche G, Maenhout B et al Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis. Clin Gastroenterol Hepatol 2006; 4: 760-5. (Pubitemid 43833506)
24. Shah SB, Parekh NK, Hanauer SB et al Intravenous cyclosporine in severe steroid-refractory ulcerative colitis: long-term follow up. Gastroenterology 2008;134:A-155.
25. Shibolet O, Regushevskaya E, Brezis M et al Cyclosporine A for induction of remission in severe ulcerative colitis. Cochrane Database Syst Rev 2005; 1: CD004277.
26. Toruner M, Lofus Jr EV Harmsen WS et al Risk factors for opportunistic infections in patients with Infammatory bowel disease. Gastroenterology 2008;134:929-36. (Pubitemid 351451967)
27. Schluender SJ, Ippoliti A, Dubinsky M et al Does Infiximab Inffuence sur-gical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis? Dis Colon Rectum 2007; 50: 1747-53. (Pubitemid 350077092)
28. Selvasekar CR, Cima RR, Larson DW et al Effect of Infiximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg 2007;204:956-62;discussion 962-953. (Pubitemid 46661200)
29. Aberra FN, Lewis JD, Hass D et al Corticosteroids and immunomodula-tors: postoperative infectious complication risk in Infammatory bowel disease patients. Gastroenterology 2003;125:320-7. (Pubitemid 36929411)
30. Colombel JF, Lofus Jr EV Tremaine WJ et al. Early postoperative complica-tions are not increased in patients with Crohn's disease treated periopera-tively with Infiximab or immunosuppressive therapy Am J Gastroenterol 2004;99:878-83. (Pubitemid 39090217)
31. Yang Z, Wu Q, Wu K et al Meta-analysis: pre-operative Infiximab treat-ment and short-term post-operative complications in patients with ulcera-tive colitis. Aliment Pharmacol Ter 2010;31:486-92.